Rafal R D, Posner M I, Walker J A, Friedrich F J
Brain. 1984 Dec;107 ( Pt 4):1083-94. doi: 10.1093/brain/107.4.1083.
Central to the concept of subcortical dementia is the implication that the increased response latencies, which distinguish the syndrome, are due to a slowing of thought processes. The term 'bradyphrenia' has been applied to this presumed slowing of thought in Parkinson's disease and implies (1) that increased response latencies are not strictly motoric but are due to slowed information processing, and (2) that the mental slowing is analogous to the bradykinesia observed in the motor domain and, hence, attributable to dysfunction of dopaminergic basal ganglia mechanisms. The current study attempts to validate this definition of bradyphrenia by seeking a slowing of thought in Parkinson's disease which can be linked directly to bradykinesia. Six parkinsonian patients with end-of-dose akinesia were studied in three experiments which allowed separation of the speed of specific cognitive operations from the speed of motor responses. Serving as their own controls, they were tested both during the parkinsonian 'off' state, and when bradykinesia was alleviated by drug therapy. Four additional patients with newly diagnosed Parkinson's disease were studied before and following successful treatment with L-DOPA/carbidopa. The first experiment measured the rate of memory scanning, the second examined orientating of attention in the visual fields, and the third measured the time required to prepare a manual movement. The results show that overall reaction time increased when patients were in the untreated state, but without a concomitant slowing of purely cognitive components. The slowing of thought often reported in Parkinson's disease does not necessarily accompany bradykinesia and thus may not be related to dopaminergic dysfunction. These findings emphasize the need for caution in inferring a slowing of thought from increased response latencies in subcortical disorders.
皮质下痴呆概念的核心在于,区分该综合征的反应潜伏期延长是由于思维过程减慢所致。“思维迟缓”一词已被用于描述帕金森病中这种假定的思维减慢,它意味着:(1)反应潜伏期延长并非严格意义上的运动迟缓,而是由于信息处理速度减慢;(2)思维减慢类似于在运动领域观察到的运动迟缓,因此可归因于多巴胺能基底神经节机制功能障碍。本研究试图通过寻找帕金森病中可直接与运动迟缓相关联的思维减慢来验证思维迟缓的这一定义。对6名处于剂末运动不能状态的帕金森病患者进行了三项实验研究,这些实验能够将特定认知操作的速度与运动反应速度区分开来。以患者自身作为对照,分别在帕金森病“关”期以及药物治疗缓解运动迟缓时对他们进行测试。另外对4名新诊断的帕金森病患者在成功接受左旋多巴/卡比多巴治疗前后进行了研究。第一个实验测量记忆扫描速度,第二个实验检查视野中的注意力定向,第三个实验测量准备手动运动所需的时间。结果显示,患者处于未治疗状态时总体反应时间增加,但纯粹认知成分并未随之减慢。帕金森病中经常报道的思维减慢并不一定伴随运动迟缓,因此可能与多巴胺能功能障碍无关。这些发现强调,在皮质下疾病中从反应潜伏期延长推断思维减慢时需谨慎。